Denise Thuilleaux

Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients

M. Tauber, Carine Mantoulan, P. Copet et al. · Orphanet Journal of Rare Diseases · 2011 · 113 citations · Full text

Medicine, Neuroscience, Psychiatry +14

AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial

Soraya Allas, Assumpta Caixàs, Christine Poitou et al. · PLoS ONE · 2018 · 97 citations · Full text

Agriculture, Pharmacology, Pharmacotherapy +13

A neuropsychological assessment of frontal cognitive functions in Prader–Willi syndrome

J. Jauregi, Carlos F. Arias, Óscar Vegas et al. · Journal of Intellectual Disability Research · 2007 · 94 citations

Social Sciences, Psychiatry, Psychology +16

Causes of death in Prader-Willi syndrome: lessons from 11 years’ experience of a national reference center

Dibia Liz Pacoricona Alfaro, P Lemoine, Virginie Ehlinger et al. · Orphanet Journal of Rare Diseases · 2019 · 92 citations · Full text

Public Health, Health Sciences, Pediatrics +13

Cognitive profile in a large french cohort of adults with Prader–Willi syndrome: differences between genotypes

P. Copet, J. Jauregi, Virginie Laurier et al. · Journal of Intellectual Disability Research · 2010 · 75 citations

Medicine, Genetics, Psychiatry +17